ASPIRIN-DIPYRIDAM ER 25-200 MG

ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
$0.5669per EA

Strength

25; 200 mg/1; mg/1

NDC

68462040560

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ASPIRIN; DIPYRIDAMOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA210318

On Market Since

5/24/2019

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor
Platelet Aggregation Inhibitor

Price History

1W

0.0%

1M

+2.0%

3M

-3.5%

6M

-2.1%

1Y

-8.1%

3Y

-19.3%

5Y

-39.2%

All

-76.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.